Search Results 401-410 of 18217 for Immunode

1. A Study to Evaluate the Effectiveness of Merimepodib in Adult Patients with Advanced COVID-1 - Mayo Clinic

   ... immunodeficiency virus (HIV), active hepatitis B or C, cirrhosis, or psychiatric illness/social situations that would limit compliance with study requirements.

2. A Study of Immune Profiling of Blood Samples in Patients with Benign and Malignant Thyroid Disorders - Mayo Clinic

   Any patient with active infection(s), fevers and/or immunodeficiency syndrome. Participating Mayo Clinic locations. Study statuses change often. Please ...

3. Publications - Giovanni De Petris, M.D. - Mayo Clinic

   Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg ...

4. Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of BL-M05D1 In Subjects With Solid Tumors - Mayo Clinic

   Subjects with known human immunodeficiency virus (HIV) infection (HIV antibody positive). Subjects are allowed to participate if all the following criteria ...

5. Belumosudil in Subjects with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Positive human immunodeficiency virus (HIV) test. Active hepatitis C virus (HCV), hepatitis B virus (HBV), or positive whole blood tuberculin test ...

6. Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma - Mayo Clinic

   Immunocompromised patients, patients with known history of testing positive for human immunodeficiency virus (HIV) or known acquired immunodeficiency ...

7. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

   Known seropositivity for or active infection by human immunodeficiency virus, hepatitis B or C, or or Severe Acute Respiratory Syndrome Coronavirus 2. Known ...

8. Trial of TRC105 and Sorafenib in Patients With HCC - Mayo Clinic

   Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness; Patients may not have received a strong CYP3A4 inducer ...

9. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Seropositive or active viral infection with hepatitis B virus, human immunodeficiency virus or hepatitis C virus. History of other malignancies, unless ...

10. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

    Known history of testing positive for Human immunodeficiency virus (HIV) or known Acquired immunodeficiency syndrome (AIDS). More information. Publications.